Faculty & Research

Overview

Faculty & research are integral components of BME. With a strong focus on research, BME is located in the heart of Canada’s largest health-care research hub. Our graduate students receive their training from 14 departments at U of T, 10 partner hospitals, and 7 research institutes & commercialization centres.

At BME, our cross-disciplinary approach in biomedical and clinical engineering enables our researchers to cover a diverse set of topics. Find out what our research publication are saying about our research focus.

Faculty directory

Core Faculty

We have 30+ core faculty members that span across cell & tissue engineering, clinical engineering, and molecular engineering disciplines.

Cross-Appointed Faculty

BME currently hosts cross-appointed faculty members across more than 30 academic units, partner hospitals, research institutes, and commercialization centres.

Emeriti

Learn about some of our retired faculty members

Research streams

Clinical

BME’s clinical engineers design technologies, devices and strategies for people with chronic disease, traumatic injury, disabilities and mobility limitations to help them integrate more fully with their environment.

Cell & Tissue

Research that has the potential to change how we think about disease and aging is happening at BME. Regenerative medicine uses stem cells and biomaterials to repair, replace or regenerate damaged tissue, organ structures and function.

Molecular

BME researchers are advancing disease detection, customizing drug delivery and improving health-care outcomes with faster and more precise technologies and systems.

Latest news

New technique improves measurement of cell barriers

Researchers at the University of Toronto have developed a novel, cost-effective method called Porous Membrane Electrical Cell–Substrate Impedance Spectroscopy (PM-ECIS) to assess the function of biological barriers in Petri dishes. In a subsequent study, the researchers characterized its sensitivity and further validated the method against a gold-standard barrier assessment technique. This new method could enhance research in fields like drug development and disease modeling.

Immune cells pave the way for advanced Heart-on-a-Chip Technology

Researchers at the University of Toronto have made strides in heart disease research by incorporating primitive macrophages—a crucial immune cell—into heart-on-a-chip technology. This innovative approach promises to enhance the functionality and stability of engineered heart tissues, potentially transforming drug testing and disease modeling.

Professor Alison McGuigan awarded Senior Scientist Award at 7th TERMIS World Congress

Professor Alison McGuigan has been honored with the prestigious Tissue Engineering and Regenerative Medicine International Society Americas Chapters (TERMIS-AM) Senior Scientist Award. This esteemed award was presented to Professor McGuigan on the final day of the 7th TERMIS World Congress Conference, held from June 25-28 in Seattle, Washington. The Senior Scientist Award is conferred upon individuals who have made significant contributions to the fields of tissue engineering and regenerative medicine.

11 BME faculty members receive a combined $500,000+ funding from NSERC 

The Discovery Grant program is dedicated to supporting researchers as they venture into new territories to find solutions to pressing issues such as environmental protection, food security, and sustainable construction in cold climates. It aims to promote and maintain a diverse and high-quality research capability in the natural sciences and engineering at Canadian universities, foster research excellence, and provide a stimulating environment for research training.

Molly Shoichet named inaugural Pamela and Paul Austin Chair in Precision and Regenerative Medicine

University Professor Molly Shoichet (ChemE, BME) has been named the inaugural Pamela and Paul Austin Chair in Precision and Regenerative Medicine. The chair, situated within the Department of Chemical Engineering & Applied Chemistry, was created in November 2023 via a gift from the The P. Austin Family Foundation.

Functional Electrical Stimulation sleeve to improve rehabilitation for motor control impairments

A recent study published in BioMedical Engineering OnLine introduces a novel smart sleeve designed for Functional Electrical Stimulation (FES) applications. This new technology integrates advanced carbon-based dry electrodes within a textile structure, offering significant improvements in comfort and usability for patients with motor control impairments.

Faculty startups

The following list highlights some of the startup companies that have been launched by these forward-thinking faculty members, demonstrating their commitment to translating academic knowledge into real-world applications and making a significant impact on the biomedical industry.

Faculty Member Commercialization Venture Focus Location 
Jan Andrysek LegWorks Prosthetic Knee Joint San Francisco 
Warren Chan Luna Nanotech Nanotechnology Product Supplier Toronto 
John E. Davies Tissue Regenerative Therapeutics Inc. Mesenchymal Stem Cells Toronto 
Milos Popovich MyndTech Inc. Medical Tech Company Mississauga 
Milica Radisic Tara Biosystems Cardiac Drug Discovery New York 
Jonathan Rocheleau QuantM3 Microfluidics Technology Diabetes Treatment Toronto 
Paul SanterreInterface Biologics Drug Delivery and other technologies Toronto 
Paul Santerre and Eli Sone Cohesys Inc Bone Tape to replace plate and screws in craniofacial repair; Angel investment Toronto 
Paul Santerre Ripple Therapeutics Non-polymeric anti-inflammatory drug delivery systems for ophthalmology; venture invested Toronto 
Molly Shoichet AmacaThera Injectable hydrogel platform technology Toronto 
Aaron Wheeler Miroculus (formerly Kappex) Digital Microfluidics Platform Toronto